Episode 71 with Dr. Brian Weinshenker on innovative clinical trials for NMO
MSDF interviews Brian Weinshenker MD of the Mayo Clinic about innovative ways to do clinical trials involving neuromyelitis optica, now considered a separate disease from MS.
MSDF interviews Brian Weinshenker MD of the Mayo Clinic about innovative ways to do clinical trials involving neuromyelitis optica, now considered a separate disease from MS.
Links to articles and other resources mentioned in Episode 71:
Note: Each podcast includes a brief summary of recent articles and updates posted to MSDF, as well as an interview with a thought leader in MS and related demyelinating diseases. Listen to it here. Alternatively, you may subscribe to the podcast via iTunes or your favorite podcast app. In iTunes, for example, click File/Subscribe to Podcast and then enter this URL: http://msdiscovery.libsyn.com/rss
This series of MS podcasts is supported in part by a generous grant from Sanofi Genzyme. The content remains the sole responsibility of the Multiple Sclerosis Discovery Forum, an independent, non-profit, news organization.
Transcript to come soon
DOI:
doi/10.7493/msdf.10.28114.1